Funds holding CONTRA APELLIS PHARMAC
ISIN US037CVR0169 · United States
- Fund holders
- 13
- Of which ETFs
- 8 5 other funds
- Value held
- 18.8K $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Bridge Builder Large Cap Growth Fund Bridge Builder Trust | 359,672 | 10.8K $ | as of Jun 30, 2026 ↗ | |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 99,674 | 3K $ | as of Jul 31, 2026 ↗ | |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 53,004 | 1.6K $ | as of Jul 31, 2026 ↗ | |
| Small Cap Stock Trust John Hancock Variable Insurance Trust | 35,572 | 1.1K $ | 0.00 % | as of Jun 30, 2026 ↗ |
| Dimensional U.S. Equity Market ETF Dimensional ETF Trust | 21,656 | 649.7 $ | as of Jul 31, 2026 ↗ | |
| Bridge Builder Small/Mid Cap Growth Fund Bridge Builder Trust | 20,780 | 623.4 $ | as of Jun 30, 2026 ↗ | |
| Dimensional US Core Equity 1 ETF Dimensional ETF Trust | 12,995 | 389.9 $ | as of Jul 31, 2026 ↗ | |
| Dimensional US Core Equity Market ETF Dimensional ETF Trust | 10,347 | 310.4 $ | as of Jul 31, 2026 ↗ | |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 4,448 | 133.4 $ | as of May 31, 2026 ↗ | |
| Morgan Stanley Pathway Large Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 4,409 | 132.3 $ | as of May 31, 2026 ↗ | |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 1,951 | 58.5 $ | as of Jun 30, 2026 ↗ | |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 585 | 17.6 $ | as of May 31, 2026 ↗ | |
| Avantis U.S. Quality ETF American Century ETF Trust | 30 | 0.9 $ | as of May 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Small Cap Stock Trust John Hancock Variable Insurance Trust | 0.00 % | as of Jun 30, 2026 ↗ |
Cite this page
Titelia. "Funds holding CONTRA APELLIS PHARMAC". https://titelia.com/en/stocks/contra-apellis-pharmac-US037CVR0169